Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Oncogene|May 3, 2006
RUNX1 associates with histone deacetylases and SUV39H1 to repress transcriptionE Reed-Inderbitzin, I Moreno-Miralles, S K Vanden-Eynden, et al.
Pharmacogenetics and Genomics|September 7, 2017
Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatmentLauren A Marcath, Allison M Deal, Emily Van Wieren, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 8, 2023
Oncologists' responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional studyTeresa M Salgado, Rotana M Radwan, Erin Hickey Zacholski, et al.
Cancer Medicine|September 11, 2024
A video intervention to improve patient understanding of tumor genomic testing in patients with cancerDeloris J Veney, Lai Y Wei, Amanda E Toland, et al.
JAMA|April 29, 2024
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized TrialWendy Y Chen, Karla V Ballman, Ann H Partridge, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 1, 2024
Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists' practicesTeresa M Salgado, Poorva B Birari, Mona Alshahawey, et al.
JNCI Cancer Spectrum|April 2, 2025
Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trialHanna Bandos, Sungjin Kim, N Lynn Henry, et al.
Future Oncology (London, England)|October 12, 2021
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancerCiara C O'Sullivan, Karla V Ballman, Linda McCall, et al.
Public Health Genomics|January 25, 2014
Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancerN T Brewer, J T Defrank, W K Chiu, et al.
Molecular and Cellular Biology|October 18, 2005
Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestineJoseph M Amann, Brenda J Irvin Chyla, Tiffany C Ellis, et al.
Pageof 7